Corteva, Inc. (CTVA) 10-Year Financial Performance & Capital Metrics

CTVA • • Industrial / General

Basic MaterialsAgricultural InputsSeed & BiotechnologySeed Technology & Traits

AboutCorteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.Show more

Revenue $16.91B -1.8%
EBITDA $3.32B
Net Income $907M +23.4%
EPS (Diluted) 1.30 +26.2%
Gross Margin 43.64% +2.9%
EBITDA Margin 19.65% +1.9%
Operating Margin 12.4% +1.2%
Net Margin 5.36% +25.7%
ROE 3.68% +27.2%
ROIC 6.45% -0.6%
Debt/Equity 0.11 +14.2%
Interest Coverage 9.00 -0.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Share count reduced 2.2% through buybacks

✗Weaknesses

✗Weak 3Y average ROE of 3.7%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y4.08%

3Y2.6%

TTM5%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-19.81%

TTM130.94%

EPS CAGR

10Y-

5Y-

3Y-18.14%

TTM136.36%

ROCE

10Y Avg3.28%

5Y Avg5.11%

3Y Avg6.39%

Latest6.65%

Peer Comparison

Seed Technology & Traits

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CTVACorteva, Inc.	47.64B	70.50	54.23	-1.85%	9.19%	6.3%	3.25%	0.11
CTA-PAEIDP, Inc.	47.43B	54.65	42.04	-1.85%	9.2%	6.4%	3.26%	0.11
RKDAArcadia Biosciences, Inc.	5.24M	2.40	-0.47	13.27%	-97.95%	-93.09%		0.02

Profit & Loss

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	14.24B	14.29B	13.85B	14.22B	15.65B	17.45B	17.23B	16.91B
Revenue Growth %	-	0%	-0.03%	0.03%	0.1%	0.11%	-0.01%	-0.02%
Cost of Goods Sold+	8.4B	9.95B	8.57B	8.51B	9.22B	10.44B	9.92B	9.53B
COGS % of Revenue	0.59%	0.7%	0.62%	0.6%	0.59%	0.6%	0.58%	0.56%
Gross Profit+	5.84B	4.34B	5.27B	5.71B	6.43B	7.02B	7.31B	7.38B
Gross Margin %	0.41%	0.3%	0.38%	0.4%	0.41%	0.4%	0.42%	0.44%
Gross Profit Growth %	-	-0.26%	0.21%	0.08%	0.13%	0.09%	0.04%	0.01%
Operating Expenses+	5.65B	4.79B	4.69B	4.87B	5.12B	5.09B	5.2B	5.28B
OpEx % of Revenue	0.4%	0.34%	0.34%	0.34%	0.33%	0.29%	0.3%	0.31%
Selling, General & Admin	2.97B	3.04B	3.06B	3.04B	3.21B	3.17B	3.18B	3.2B
SG&A % of Revenue	0.21%	0.21%	0.22%	0.21%	0.2%	0.18%	0.18%	0.19%
Research & Development	1.51B	1.35B	1.15B	1.14B	1.19B	1.22B	1.34B	1.4B
R&D % of Revenue	0.11%	0.09%	0.08%	0.08%	0.08%	0.07%	0.08%	0.08%
Other Operating Expenses	1.17B	391M	475M	682M	722M	702M	683M	685M
Operating Income+	188M	-448M	584M	843M	1.32B	1.93B	2.11B	2.1B
Operating Margin %	0.01%	-0.03%	0.04%	0.06%	0.08%	0.11%	0.12%	0.12%
Operating Income Growth %	-	-3.38%	2.3%	0.44%	0.56%	0.46%	0.09%	-0.01%
EBITDA+	458M	2.34B	2.18B	2.02B	2.56B	3.15B	3.32B	3.32B
EBITDA Margin %	0.03%	0.16%	0.16%	0.14%	0.16%	0.18%	0.19%	0.2%
EBITDA Growth %	-	4.11%	-0.07%	-0.07%	0.27%	0.23%	0.05%	0%
D&A (Non-Cash Add-back)	270M	2.79B	1.6B	1.18B	1.24B	1.22B	1.21B	1.23B
EBIT	-300M	-6.47B	-180M	720M	2.38B	1.5B	1.33B	1.51B
Net Interest Income+	-74M	-251M	-77M	11M	47M	45M	50M	-101M
Interest Income	0	86M	59M	56M	77M	124M	283M	132M
Interest Expense	74M	337M	136M	45M	30M	79M	233M	233M
Other Income/Expense	-562M	-6.36B	-900M	-168M	1.03B	-502M	-1.02B	-821M
Pretax Income+	-374M	-6.81B	-316M	675M	2.35B	1.43B	1.09B	1.27B
Pretax Margin %	-0.03%	-0.48%	-0.02%	0.05%	0.15%	0.08%	0.06%	0.08%
Income Tax+	-2.52B	-31M	-46M	-81M	524M	210M	152M	412M
Effective Tax Rate %	-6.78%	0.74%	3.03%	1.01%	0.75%	0.8%	0.67%	0.71%
Net Income+	2.53B	-5.07B	-959M	681M	1.76B	1.15B	735M	907M
Net Margin %	0.18%	-0.35%	-0.07%	0.05%	0.11%	0.07%	0.04%	0.05%
Net Income Growth %	-	-3%	0.81%	1.71%	1.58%	-0.35%	-0.36%	0.23%
Net Income (Continuing)	2.57B	-6.78B	-270M	756M	1.82B	1.22B	941M	863M
Discontinued Operations	0	1.75B	-671M	-55M	-53M	-58M	-194M	56M
Minority Interest	172M	493M	246M	239M	239M	239M	242M	241M
EPS (Diluted)+	3.38	-6.76	-1.28	0.91	2.37	1.58	1.03	1.30
EPS Growth %	-	-3%	0.81%	1.71%	1.6%	-0.33%	-0.35%	0.26%
EPS (Basic)	3.38	-6.76	-1.28	0.91	2.39	1.59	1.04	1.31
Diluted Shares Outstanding	749.4M	749.4M	749.5M	751.2M	741.6M	724.5M	711.9M	696M
Basic Shares Outstanding	749.4M	749.4M	749.5M	748.7M	735.9M	720.8M	709M	693.7M
Dividend Payout Ratio	0.72%	-	-	0.57%	0.23%	0.36%	0.6%	0.5%

Balance Sheet

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	23.05B	22.97B	13.52B	14.77B	15.55B	16.8B	16.26B	15.1B
Cash & Short-Term Investments	8.76B	2.27B	1.77B	3.79B	4.54B	3.31B	2.74B	3.17B
Cash Only	7.81B	2.27B	1.76B	3.53B	4.46B	3.19B	2.64B	3.11B
Short-Term Investments	952M	5M	5M	269M	86M	124M	98M	63M
Accounts Receivable	5.24B	5.26B	5.53B	4.93B	4.81B	5.7B	5.49B	5.68B
Days Sales Outstanding	134.29	134.38	145.73	126.47	112.17	119.21	116.28	122.53
Inventory	8.63B	5.31B	5.03B	4.88B	5.18B	6.81B	6.9B	5.43B
Days Inventory Outstanding	375.04	194.83	214.19	209.47	205.07	238.22	253.84	208.07
Other Current Assets	423M	10.13B	1.19B	1.17B	1.01B	968M	1.13B	820M
Total Non-Current Assets+	89.91B	85.71B	28.88B	27.88B	26.8B	25.82B	26.74B	25.73B
Property, Plant & Equipment	12.44B	4.54B	4.55B	4.4B	4.33B	4.25B	4.29B	4.1B
Fixed Asset Turnover	1.15x	3.14x	3.05x	3.23x	3.62x	4.10x	4.02x	4.12x
Goodwill	45.59B	10.19B	10.23B	10.27B	10.11B	9.96B	10.61B	10.41B
Intangible Assets	0	12.05B	11.42B	10.75B	10.04B	9.34B	9.63B	8.88B
Long-Term Investments	1.59B	138M	66M	66M	76M	102M	115M	134M
Other Non-Current Assets	29.81B	58.48B	2.33B	1.94B	1.8B	1.69B	1.52B	1.81B
Total Assets+	112.96B	108.68B	42.4B	42.65B	42.34B	42.62B	43B	40.83B
Asset Turnover	0.13x	0.13x	0.33x	0.33x	0.37x	0.41x	0.40x	0.41x
Asset Growth %	-	-0.04%	-0.61%	0.01%	-0.01%	0.01%	0.01%	-0.05%
Total Current Liabilities+	12.14B	13.31B	8.24B	8.55B	9.56B	10.74B	10.41B	10.39B
Accounts Payable	4.83B	3.8B	3.7B	3.62B	4.13B	4.89B	4.28B	4.04B
Days Payables Outstanding	209.87	139.35	157.58	155.1	163.34	171.2	157.48	154.71
Short-Term Debt	2.78B	2.13B	3M	3M	17M	23M	197M	750M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	2.52B	3.17B	381M	232M	0	0	0	0
Current Ratio	1.90x	1.73x	1.64x	1.73x	1.63x	1.56x	1.56x	1.45x
Quick Ratio	1.19x	1.33x	1.03x	1.16x	1.08x	0.93x	0.90x	0.93x
Cash Conversion Cycle	299.45	189.86	202.34	180.83	153.9	186.23	212.65	175.89
Total Non-Current Liabilities+	25.89B	20.22B	9.6B	9.04B	7.16B	6.33B	7.31B	6.41B
Long-Term Debt	10.29B	5.72B	115M	1.1B	1.1B	1.28B	2.29B	1.95B
Capital Lease Obligations	4M	67M	5M	0	3M	2M	0	0
Deferred Tax Liabilities	5.84B	0	920M	893M	1.22B	1.12B	899M	478M
Other Non-Current Liabilities	9.71B	14.44B	8.56B	7.04B	4.84B	3.93B	4.12B	3.98B
Total Liabilities	38.03B	33.53B	17.84B	17.59B	16.72B	17.08B	17.72B	16.8B
Total Debt+	13.07B	7.94B	127M	1.11B	1.12B	1.31B	2.49B	2.7B
Net Debt	5.26B	5.67B	-1.64B	-2.42B	-3.34B	-1.88B	-155M	-403M
Debt / Equity	0.17x	0.11x	0.01x	0.04x	0.04x	0.05x	0.10x	0.11x
Debt / EBITDA	28.54x	3.39x	0.06x	0.55x	0.44x	0.41x	0.75x	0.81x
Net Debt / EBITDA	11.49x	2.42x	-0.75x	-1.20x	-1.30x	-0.60x	-0.05x	-0.12x
Interest Coverage	2.54x	-1.33x	4.29x	18.73x	43.90x	24.41x	9.06x	9.00x
Total Equity+	74.93B	75.15B	24.55B	25.06B	25.62B	25.54B	25.28B	24.03B
Equity Growth %	-	0%	-0.67%	0.02%	0.02%	-0%	-0.01%	-0.05%
Book Value per Share	99.99	100.28	32.76	33.36	34.55	35.25	35.51	34.53
Total Shareholders' Equity	74.76B	74.66B	24.31B	24.82B	25.38B	25.3B	25.04B	23.79B
Common Stock	0	0	7M	7M	7M	7M	7M	7M
Retained Earnings	175M	0	-425M	0	524M	250M	-41M	55M
Treasury Stock	0	0	0	0	0	0	0	0
Accumulated OCI	-381M	74.66B	-3.27B	-2.89B	-2.9B	-2.81B	-2.68B	-3.47B
Minority Interest	172M	493M	246M	239M	239M	239M	242M	241M

Cash Flow

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	247M	483M	1.07B	2.06B	2.73B	872M	1.77B	2.15B
Operating CF Margin %	0.02%	0.03%	0.08%	0.15%	0.17%	0.05%	0.1%	0.13%
Operating CF Growth %	-	0.96%	1.22%	0.93%	0.32%	-0.68%	1.03%	0.21%
Net Income	2.71B	-5.07B	-941M	701M	1.82B	1.21B	941M	863M
Depreciation & Amortization	1.54B	2.79B	1.6B	1.18B	1.24B	1.22B	1.21B	1.23B
Stock-Based Compensation	0	0	84M	0	0	55M	0	0
Deferred Taxes	-3.02B	31M	-477M	-330M	174M	-286M	-438M	-365M
Other Non-Cash Items	-334M	5.67B	1.36B	19M	-1.17B	224M	841M	512M
Working Capital Changes	-656M	-2.94B	-556M	497M	656M	-1.55B	-786M	-92M
Change in Receivables	-162M	-1.52B	0	187M	-113M	-997M	358M	-705M
Change in Inventory	-1.01B	-498M	74M	104M	-422M	-1.72B	57M	1.11B
Change in Payables	934M	642M	149M	-118M	524M	807M	-663M	-115M
Cash from Investing+	386M	-505M	-904M	-674M	-362M	-632M	-1.99B	-589M
Capital Expenditures	-1.11B	-1.5B	-1.16B	-475M	-573M	-605M	-595M	-597M
CapEx % of Revenue	0.08%	0.11%	0.08%	0.03%	0.04%	0.03%	0.03%	0.04%
Acquisitions	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-
Other Investing	-214M	75M	236M	85M	74M	34M	45M	-34M
Cash from Financing+	2.4B	-2.62B	-2.93B	303M	-1.27B	-1.18B	-99M	-1.2B
Debt Issued (Net)	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-
Dividends Paid	-988M	-2.81B	-511M	-388M	-397M	-418M	-439M	-458M
Share Repurchases	-	-	-	-	-	-	-	-
Other Financing	-903M	4.98B	5.28B	-32M	70M	33M	-18M	28M
Net Change in Cash	-	-	-	-	-	-	-	-
Free Cash Flow+	-866M	-1.02B	-93M	1.59B	2.15B	267M	1.17B	1.55B
FCF Margin %	-0.06%	-0.07%	-0.01%	0.11%	0.14%	0.02%	0.07%	0.09%
FCF Growth %	-	-0.18%	0.91%	18.09%	0.36%	-0.88%	3.4%	0.32%
FCF per Share	-1.16	-1.36	-0.12	2.12	2.90	0.37	1.65	2.22
FCF Conversion (FCF/Net Income)	0.10x	-0.10x	-1.12x	3.03x	1.55x	0.76x	2.41x	2.36x
Interest Paid	0	923M	263M	36M	30M	75M	234M	244M
Taxes Paid	0	961M	234M	229M	341M	467M	535M	707M

Key Ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	3.38%	-6.75%	-1.92%	2.74%	6.94%	4.48%	2.89%	3.68%
Return on Invested Capital (ROIC)	0.18%	-0.42%	0.84%	2.78%	4.4%	6.3%	6.49%	6.45%
Gross Margin	41%	30.37%	38.07%	40.16%	41.11%	40.21%	42.41%	43.64%
Net Margin	17.79%	-35.45%	-6.93%	4.79%	11.24%	6.57%	4.27%	5.36%
Debt / Equity	0.17x	0.11x	0.01x	0.04x	0.04x	0.05x	0.10x	0.11x
Interest Coverage	2.54x	-1.33x	4.29x	18.73x	43.90x	24.41x	9.06x	9.00x
FCF Conversion	0.10x	-0.10x	-1.12x	3.03x	1.55x	0.76x	2.41x	2.36x
Revenue Growth	-	0.33%	-3.09%	2.68%	10.11%	11.5%	-1.31%	-1.85%

Revenue by Segment

	2019	2020	2021	2022	2023	2024
Seed	5.11B	5.18B	5.62B	5.96B	6.45B	6.5B
Seed Growth	-	1.39%	8.41%	6.00%	8.26%	0.76%
Crop Protection	3.27B	3.28B	3.81B	4.59B	4.03B	3.6B
Crop Protection Growth	-	0.31%	16.31%	20.34%	-12.13%	-10.78%

Revenue by Geography

	2019	2020	2021	2022	2023	2024
UNITED STATES	6.25B	6.51B	6.78B	7.55B	7.78B	7.87B
UNITED STATES Growth	-	4.08%	4.18%	11.37%	3.05%	1.07%
Latin America	2.89B	2.81B	3.54B	4.45B	3.91B	3.78B
Latin America Growth	-	-2.91%	26.38%	25.39%	-12.13%	-3.33%
EMEA	2.74B	2.84B	3.12B	3.26B	3.37B	3.12B
EMEA Growth	-	3.72%	9.89%	4.26%	3.41%	-7.22%
Asia Pacific	1.29B	1.4B	1.45B	1.46B	1.36B	1.35B
Asia Pacific Growth	-	8.85%	3.50%	0.62%	-6.64%	-1.10%
CANADA	674M	658M	754M	741M	807M	794M
CANADA Growth	-	-2.37%	14.59%	-1.72%	8.91%	-1.61%

Frequently Asked Questions

Valuation & Price

Corteva, Inc. (CTVA) has a price-to-earnings (P/E) ratio of 54.2x. This suggests investors expect higher future growth.

Growth & Financials

Corteva, Inc. (CTVA) reported $17.47B in revenue for fiscal year 2024. This represents a 23% increase from $14.24B in 2017.

Corteva, Inc. (CTVA) saw revenue decline by 1.8% over the past year.

Yes, Corteva, Inc. (CTVA) is profitable, generating $1.60B in net income for fiscal year 2024 (5.4% net margin).

Dividend & Returns

Yes, Corteva, Inc. (CTVA) pays a dividend with a yield of 0.93%. This makes it attractive for income-focused investors.

Corteva, Inc. (CTVA) has a return on equity (ROE) of 3.7%. This is below average, suggesting room for improvement.

Corteva, Inc. (CTVA) generated $2.65B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Corteva, Inc. (CTVA) 10-Year Financial Performance & Capital Metrics

CTVA • • Industrial / General

Basic MaterialsAgricultural InputsSeed & BiotechnologySeed Technology & Traits

Revenue $16.91B -1.8%
EBITDA $3.32B
Net Income $907M +23.4%
EPS (Diluted) 1.30 +26.2%
Gross Margin 43.64% +2.9%
EBITDA Margin 19.65% +1.9%
Operating Margin 12.4% +1.2%
Net Margin 5.36% +25.7%
ROE 3.68% +27.2%
ROIC 6.45% -0.6%
Debt/Equity 0.11 +14.2%
Interest Coverage 9.00 -0.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Share count reduced 2.2% through buybacks

✗Weaknesses

✗Weak 3Y average ROE of 3.7%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y4.08%

3Y2.6%

TTM5%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-19.81%

TTM130.94%

EPS CAGR

10Y-

5Y-

3Y-18.14%

TTM136.36%

ROCE

10Y Avg3.28%

5Y Avg5.11%

3Y Avg6.39%

Latest6.65%

Peer Comparison

Seed Technology & Traits

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CTVACorteva, Inc.	47.64B	70.50	54.23	-1.85%	9.19%	6.3%	3.25%	0.11
CTA-PAEIDP, Inc.	47.43B	54.65	42.04	-1.85%	9.2%	6.4%	3.26%	0.11
RKDAArcadia Biosciences, Inc.	5.24M	2.40	-0.47	13.27%	-97.95%	-93.09%		0.02

Profit & Loss

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	14.24B	14.29B	13.85B	14.22B	15.65B	17.45B	17.23B	16.91B
Revenue Growth %	-	0%	-0.03%	0.03%	0.1%	0.11%	-0.01%	-0.02%
Cost of Goods Sold+	8.4B	9.95B	8.57B	8.51B	9.22B	10.44B	9.92B	9.53B
COGS % of Revenue	0.59%	0.7%	0.62%	0.6%	0.59%	0.6%	0.58%	0.56%
Gross Profit+	5.84B	4.34B	5.27B	5.71B	6.43B	7.02B	7.31B	7.38B
Gross Margin %	0.41%	0.3%	0.38%	0.4%	0.41%	0.4%	0.42%	0.44%
Gross Profit Growth %	-	-0.26%	0.21%	0.08%	0.13%	0.09%	0.04%	0.01%
Operating Expenses+	5.65B	4.79B	4.69B	4.87B	5.12B	5.09B	5.2B	5.28B
OpEx % of Revenue	0.4%	0.34%	0.34%	0.34%	0.33%	0.29%	0.3%	0.31%
Selling, General & Admin	2.97B	3.04B	3.06B	3.04B	3.21B	3.17B	3.18B	3.2B
SG&A % of Revenue	0.21%	0.21%	0.22%	0.21%	0.2%	0.18%	0.18%	0.19%
Research & Development	1.51B	1.35B	1.15B	1.14B	1.19B	1.22B	1.34B	1.4B
R&D % of Revenue	0.11%	0.09%	0.08%	0.08%	0.08%	0.07%	0.08%	0.08%
Other Operating Expenses	1.17B	391M	475M	682M	722M	702M	683M	685M
Operating Income+	188M	-448M	584M	843M	1.32B	1.93B	2.11B	2.1B
Operating Margin %	0.01%	-0.03%	0.04%	0.06%	0.08%	0.11%	0.12%	0.12%
Operating Income Growth %	-	-3.38%	2.3%	0.44%	0.56%	0.46%	0.09%	-0.01%
EBITDA+	458M	2.34B	2.18B	2.02B	2.56B	3.15B	3.32B	3.32B
EBITDA Margin %	0.03%	0.16%	0.16%	0.14%	0.16%	0.18%	0.19%	0.2%
EBITDA Growth %	-	4.11%	-0.07%	-0.07%	0.27%	0.23%	0.05%	0%
D&A (Non-Cash Add-back)	270M	2.79B	1.6B	1.18B	1.24B	1.22B	1.21B	1.23B
EBIT	-300M	-6.47B	-180M	720M	2.38B	1.5B	1.33B	1.51B
Net Interest Income+	-74M	-251M	-77M	11M	47M	45M	50M	-101M
Interest Income	0	86M	59M	56M	77M	124M	283M	132M
Interest Expense	74M	337M	136M	45M	30M	79M	233M	233M
Other Income/Expense	-562M	-6.36B	-900M	-168M	1.03B	-502M	-1.02B	-821M
Pretax Income+	-374M	-6.81B	-316M	675M	2.35B	1.43B	1.09B	1.27B
Pretax Margin %	-0.03%	-0.48%	-0.02%	0.05%	0.15%	0.08%	0.06%	0.08%
Income Tax+	-2.52B	-31M	-46M	-81M	524M	210M	152M	412M
Effective Tax Rate %	-6.78%	0.74%	3.03%	1.01%	0.75%	0.8%	0.67%	0.71%
Net Income+	2.53B	-5.07B	-959M	681M	1.76B	1.15B	735M	907M
Net Margin %	0.18%	-0.35%	-0.07%	0.05%	0.11%	0.07%	0.04%	0.05%
Net Income Growth %	-	-3%	0.81%	1.71%	1.58%	-0.35%	-0.36%	0.23%
Net Income (Continuing)	2.57B	-6.78B	-270M	756M	1.82B	1.22B	941M	863M
Discontinued Operations	0	1.75B	-671M	-55M	-53M	-58M	-194M	56M
Minority Interest	172M	493M	246M	239M	239M	239M	242M	241M
EPS (Diluted)+	3.38	-6.76	-1.28	0.91	2.37	1.58	1.03	1.30
EPS Growth %	-	-3%	0.81%	1.71%	1.6%	-0.33%	-0.35%	0.26%
EPS (Basic)	3.38	-6.76	-1.28	0.91	2.39	1.59	1.04	1.31
Diluted Shares Outstanding	749.4M	749.4M	749.5M	751.2M	741.6M	724.5M	711.9M	696M
Basic Shares Outstanding	749.4M	749.4M	749.5M	748.7M	735.9M	720.8M	709M	693.7M
Dividend Payout Ratio	0.72%	-	-	0.57%	0.23%	0.36%	0.6%	0.5%

Balance Sheet

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	23.05B	22.97B	13.52B	14.77B	15.55B	16.8B	16.26B	15.1B
Cash & Short-Term Investments	8.76B	2.27B	1.77B	3.79B	4.54B	3.31B	2.74B	3.17B
Cash Only	7.81B	2.27B	1.76B	3.53B	4.46B	3.19B	2.64B	3.11B
Short-Term Investments	952M	5M	5M	269M	86M	124M	98M	63M
Accounts Receivable	5.24B	5.26B	5.53B	4.93B	4.81B	5.7B	5.49B	5.68B
Days Sales Outstanding	134.29	134.38	145.73	126.47	112.17	119.21	116.28	122.53
Inventory	8.63B	5.31B	5.03B	4.88B	5.18B	6.81B	6.9B	5.43B
Days Inventory Outstanding	375.04	194.83	214.19	209.47	205.07	238.22	253.84	208.07
Other Current Assets	423M	10.13B	1.19B	1.17B	1.01B	968M	1.13B	820M
Total Non-Current Assets+	89.91B	85.71B	28.88B	27.88B	26.8B	25.82B	26.74B	25.73B
Property, Plant & Equipment	12.44B	4.54B	4.55B	4.4B	4.33B	4.25B	4.29B	4.1B
Fixed Asset Turnover	1.15x	3.14x	3.05x	3.23x	3.62x	4.10x	4.02x	4.12x
Goodwill	45.59B	10.19B	10.23B	10.27B	10.11B	9.96B	10.61B	10.41B
Intangible Assets	0	12.05B	11.42B	10.75B	10.04B	9.34B	9.63B	8.88B
Long-Term Investments	1.59B	138M	66M	66M	76M	102M	115M	134M
Other Non-Current Assets	29.81B	58.48B	2.33B	1.94B	1.8B	1.69B	1.52B	1.81B
Total Assets+	112.96B	108.68B	42.4B	42.65B	42.34B	42.62B	43B	40.83B
Asset Turnover	0.13x	0.13x	0.33x	0.33x	0.37x	0.41x	0.40x	0.41x
Asset Growth %	-	-0.04%	-0.61%	0.01%	-0.01%	0.01%	0.01%	-0.05%
Total Current Liabilities+	12.14B	13.31B	8.24B	8.55B	9.56B	10.74B	10.41B	10.39B
Accounts Payable	4.83B	3.8B	3.7B	3.62B	4.13B	4.89B	4.28B	4.04B
Days Payables Outstanding	209.87	139.35	157.58	155.1	163.34	171.2	157.48	154.71
Short-Term Debt	2.78B	2.13B	3M	3M	17M	23M	197M	750M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	2.52B	3.17B	381M	232M	0	0	0	0
Current Ratio	1.90x	1.73x	1.64x	1.73x	1.63x	1.56x	1.56x	1.45x
Quick Ratio	1.19x	1.33x	1.03x	1.16x	1.08x	0.93x	0.90x	0.93x
Cash Conversion Cycle	299.45	189.86	202.34	180.83	153.9	186.23	212.65	175.89
Total Non-Current Liabilities+	25.89B	20.22B	9.6B	9.04B	7.16B	6.33B	7.31B	6.41B
Long-Term Debt	10.29B	5.72B	115M	1.1B	1.1B	1.28B	2.29B	1.95B
Capital Lease Obligations	4M	67M	5M	0	3M	2M	0	0
Deferred Tax Liabilities	5.84B	0	920M	893M	1.22B	1.12B	899M	478M
Other Non-Current Liabilities	9.71B	14.44B	8.56B	7.04B	4.84B	3.93B	4.12B	3.98B
Total Liabilities	38.03B	33.53B	17.84B	17.59B	16.72B	17.08B	17.72B	16.8B
Total Debt+	13.07B	7.94B	127M	1.11B	1.12B	1.31B	2.49B	2.7B
Net Debt	5.26B	5.67B	-1.64B	-2.42B	-3.34B	-1.88B	-155M	-403M
Debt / Equity	0.17x	0.11x	0.01x	0.04x	0.04x	0.05x	0.10x	0.11x
Debt / EBITDA	28.54x	3.39x	0.06x	0.55x	0.44x	0.41x	0.75x	0.81x
Net Debt / EBITDA	11.49x	2.42x	-0.75x	-1.20x	-1.30x	-0.60x	-0.05x	-0.12x
Interest Coverage	2.54x	-1.33x	4.29x	18.73x	43.90x	24.41x	9.06x	9.00x
Total Equity+	74.93B	75.15B	24.55B	25.06B	25.62B	25.54B	25.28B	24.03B
Equity Growth %	-	0%	-0.67%	0.02%	0.02%	-0%	-0.01%	-0.05%
Book Value per Share	99.99	100.28	32.76	33.36	34.55	35.25	35.51	34.53
Total Shareholders' Equity	74.76B	74.66B	24.31B	24.82B	25.38B	25.3B	25.04B	23.79B
Common Stock	0	0	7M	7M	7M	7M	7M	7M
Retained Earnings	175M	0	-425M	0	524M	250M	-41M	55M
Treasury Stock	0	0	0	0	0	0	0	0
Accumulated OCI	-381M	74.66B	-3.27B	-2.89B	-2.9B	-2.81B	-2.68B	-3.47B
Minority Interest	172M	493M	246M	239M	239M	239M	242M	241M

Cash Flow

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	247M	483M	1.07B	2.06B	2.73B	872M	1.77B	2.15B
Operating CF Margin %	0.02%	0.03%	0.08%	0.15%	0.17%	0.05%	0.1%	0.13%
Operating CF Growth %	-	0.96%	1.22%	0.93%	0.32%	-0.68%	1.03%	0.21%
Net Income	2.71B	-5.07B	-941M	701M	1.82B	1.21B	941M	863M
Depreciation & Amortization	1.54B	2.79B	1.6B	1.18B	1.24B	1.22B	1.21B	1.23B
Stock-Based Compensation	0	0	84M	0	0	55M	0	0
Deferred Taxes	-3.02B	31M	-477M	-330M	174M	-286M	-438M	-365M
Other Non-Cash Items	-334M	5.67B	1.36B	19M	-1.17B	224M	841M	512M
Working Capital Changes	-656M	-2.94B	-556M	497M	656M	-1.55B	-786M	-92M
Change in Receivables	-162M	-1.52B	0	187M	-113M	-997M	358M	-705M
Change in Inventory	-1.01B	-498M	74M	104M	-422M	-1.72B	57M	1.11B
Change in Payables	934M	642M	149M	-118M	524M	807M	-663M	-115M
Cash from Investing+	386M	-505M	-904M	-674M	-362M	-632M	-1.99B	-589M
Capital Expenditures	-1.11B	-1.5B	-1.16B	-475M	-573M	-605M	-595M	-597M
CapEx % of Revenue	0.08%	0.11%	0.08%	0.03%	0.04%	0.03%	0.03%	0.04%
Acquisitions	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-
Other Investing	-214M	75M	236M	85M	74M	34M	45M	-34M
Cash from Financing+	2.4B	-2.62B	-2.93B	303M	-1.27B	-1.18B	-99M	-1.2B
Debt Issued (Net)	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-
Dividends Paid	-988M	-2.81B	-511M	-388M	-397M	-418M	-439M	-458M
Share Repurchases	-	-	-	-	-	-	-	-
Other Financing	-903M	4.98B	5.28B	-32M	70M	33M	-18M	28M
Net Change in Cash	-	-	-	-	-	-	-	-
Free Cash Flow+	-866M	-1.02B	-93M	1.59B	2.15B	267M	1.17B	1.55B
FCF Margin %	-0.06%	-0.07%	-0.01%	0.11%	0.14%	0.02%	0.07%	0.09%
FCF Growth %	-	-0.18%	0.91%	18.09%	0.36%	-0.88%	3.4%	0.32%
FCF per Share	-1.16	-1.36	-0.12	2.12	2.90	0.37	1.65	2.22
FCF Conversion (FCF/Net Income)	0.10x	-0.10x	-1.12x	3.03x	1.55x	0.76x	2.41x	2.36x
Interest Paid	0	923M	263M	36M	30M	75M	234M	244M
Taxes Paid	0	961M	234M	229M	341M	467M	535M	707M

Key Ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	3.38%	-6.75%	-1.92%	2.74%	6.94%	4.48%	2.89%	3.68%
Return on Invested Capital (ROIC)	0.18%	-0.42%	0.84%	2.78%	4.4%	6.3%	6.49%	6.45%
Gross Margin	41%	30.37%	38.07%	40.16%	41.11%	40.21%	42.41%	43.64%
Net Margin	17.79%	-35.45%	-6.93%	4.79%	11.24%	6.57%	4.27%	5.36%
Debt / Equity	0.17x	0.11x	0.01x	0.04x	0.04x	0.05x	0.10x	0.11x
Interest Coverage	2.54x	-1.33x	4.29x	18.73x	43.90x	24.41x	9.06x	9.00x
FCF Conversion	0.10x	-0.10x	-1.12x	3.03x	1.55x	0.76x	2.41x	2.36x
Revenue Growth	-	0.33%	-3.09%	2.68%	10.11%	11.5%	-1.31%	-1.85%

Revenue by Segment

	2019	2020	2021	2022	2023	2024
Seed	5.11B	5.18B	5.62B	5.96B	6.45B	6.5B
Seed Growth	-	1.39%	8.41%	6.00%	8.26%	0.76%
Crop Protection	3.27B	3.28B	3.81B	4.59B	4.03B	3.6B
Crop Protection Growth	-	0.31%	16.31%	20.34%	-12.13%	-10.78%

Revenue by Geography

	2019	2020	2021	2022	2023	2024
UNITED STATES	6.25B	6.51B	6.78B	7.55B	7.78B	7.87B
UNITED STATES Growth	-	4.08%	4.18%	11.37%	3.05%	1.07%
Latin America	2.89B	2.81B	3.54B	4.45B	3.91B	3.78B
Latin America Growth	-	-2.91%	26.38%	25.39%	-12.13%	-3.33%
EMEA	2.74B	2.84B	3.12B	3.26B	3.37B	3.12B
EMEA Growth	-	3.72%	9.89%	4.26%	3.41%	-7.22%
Asia Pacific	1.29B	1.4B	1.45B	1.46B	1.36B	1.35B
Asia Pacific Growth	-	8.85%	3.50%	0.62%	-6.64%	-1.10%
CANADA	674M	658M	754M	741M	807M	794M
CANADA Growth	-	-2.37%	14.59%	-1.72%	8.91%	-1.61%

Frequently Asked Questions

Valuation & Price

Corteva, Inc. (CTVA) has a price-to-earnings (P/E) ratio of 54.2x. This suggests investors expect higher future growth.

Growth & Financials

Corteva, Inc. (CTVA) reported $17.47B in revenue for fiscal year 2024. This represents a 23% increase from $14.24B in 2017.

Corteva, Inc. (CTVA) saw revenue decline by 1.8% over the past year.

Yes, Corteva, Inc. (CTVA) is profitable, generating $1.60B in net income for fiscal year 2024 (5.4% net margin).

Dividend & Returns

Yes, Corteva, Inc. (CTVA) pays a dividend with a yield of 0.93%. This makes it attractive for income-focused investors.

Corteva, Inc. (CTVA) has a return on equity (ROE) of 3.7%. This is below average, suggesting room for improvement.

Corteva, Inc. (CTVA) generated $2.65B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.